D-0497-2025 Class II
FDA drug recall D-0497-2025 was initiated by Zydus Pharmaceuticals (USA) Inc on May 30, 2025 and is designated Class II. Reason for recall: Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents. Affected quantity: 11,616 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 18, 2025
- Initiation Date
- May 30, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,616 bottles
Product description
Icosapent Ethyl Capsules 1 gram, 120 Capsules per Bottle, Rx Only, Manufactured by Doppel Farmaceutici s.r.l., Piacenza, Italy, Distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-7.
Reason for recall
Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents.
Distribution pattern
IL, PA, & MS
Code information
Lot #s: B237040, B237041, Exp 10/31/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0497-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026